Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 4 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 29 Ovarian Neoplasms 27 Breast Neoplasms 27 Lung Neoplasms 26 Carcinoma, Ovarian Epithelial 20 Fallopian Tube Neoplasms 15 Adenocarcinoma of Lung 14 Head and Neck Neoplasms 13 Brenner Tumor 11 Uterine Cervical Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Urinary Bladder Neoplasms 9 Esophageal Neoplasms 9 Stomach Neoplasms 8 Endometrial Neoplasms 8 Urethral Neoplasms 7 Adenocarcinoma, Bronchiolo-Alveolar 6 Sarcoma 5 Prostatic Neoplasms 5 Adenocarcinoma Of Esophagus 5 Neurotoxicity Syndromes 4 Neoplasm Metastasis 4 Testicular Neoplasms 3 Salivary Gland Neoplasms 3 Radiation Injuries 3 Esophageal Squamous Cell Carcinoma 3 Breast Neoplasms, Male 3 Thymoma 2 Testicular Germ Cell Tumor 2 Small Cell Lung Carcinoma 2

Interventions

Gemcitabine 10 Cisplatin 7 S 1 (combination) 6 titanium silicide 2 Oxaliplatin 2 spartalizumab 1 pembrolizumab 1 pamiparib 1 atezolizumab 1 World Health Organization oral rehydration solution 1 Temozolomide 1 Paclitaxel 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Biliary Tract Neoplasms × Paclitaxel × Clear all

NCT03818997 2020-02-05

DYNAMIC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡